Autoantibodies in the grocery shop: does quantity matter?

J. Damoiseaux*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Testing for autoantibodies is an integrated part in the diagnostic process of many autoimmune diseases. As a consequence, the detection of autoantibodies is increasingly recognized in classification criteria and diagnostic guidelines. In this review, the question is addressed whether quantification of autoantibodies is clinically useful, not only in the diagnostic stage, but also during follow-up of patients with autoimmune diseases. It can be concluded that for a multitude of autoantibodies, there is sufficient evidence that the higher the amount of autoantibodies, the more likely that the patient has the respective autoimmune disease. Quantification is also of added value for monitoring therapeutic efficacy, although this depends on the type of therapy that is installed. The relation between rises in autoantibody levels and the occurrence of subsequent disease relapses, however, is far from absolute. Obviously, if quantification of autoantibodies is performed in the laboratory, results should also be reported quantitatively together with an appropriate interpretation for the clinician.
Original languageEnglish
Pages (from-to)413-419
JournalImmunologic Research
Issue number2-3
Publication statusPublished - 1 Jan 2013


Dive into the research topics of 'Autoantibodies in the grocery shop: does quantity matter?'. Together they form a unique fingerprint.

Cite this